Aethlon Medical
AEMD
12 hedge funds and large institutions have $187K invested in Aethlon Medical in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
180% more capital inflows, than outflows
Capital inflows: $127K | Capital outflows: $45.3K
1.61% more ownership
Funds ownership: 1.3% → 2.91% (+1.6%)
8% less funds holding
Funds holding: 13 → 12 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$86.1K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$31K |
| 3 |
Two Sigma Investments
New York
|
+$6.2K |
| 4 |
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$1.59K |
| 5 |
Citigroup
New York
|
+$953 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$18.3K |
| 2 |
Jane Street
New York
|
-$13.2K |
| 3 |
Two Sigma Securities
New York
|
-$8.26K |
| 4 |
HRT Financial
New York
|
-$5K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$549 |
AEMD Hedge Fund Activity: Q3 2024 in Review
12 of the 6,989 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2024, worth a combined $187K — up 109% from $89.2K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AEMD and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.
The largest buyer was UBS Group, adding an estimated $86.1K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $18.3K sold.
- 12 institutional investors held Aethlon Medical (AEMD) as of Q3 2024, down from 13 in Q2 2024.
- Funds reported $187K of Aethlon Medical stock for Q3 2024, up 109% quarter-over-quarter.
- 3 funds opened new Aethlon Medical positions in Q3 2024 and 4 closed out, a net change of -1 holder.
- The largest Aethlon Medical buyer in Q3 2024 was UBS Group, an estimated $86.1K added.
- The largest Aethlon Medical seller in Q3 2024 was Susquehanna International Group, an estimated $18.3K sold.
Based on aggregated 13F filings for Q3 2024.